Related Experiment Video
Updated: Oct 8, 2025

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
Published on: February 17, 2019
Targeting Programmed Cell Death to Improve Stem Cell Therapy: Implications for Treating Diabetes and Diabetes-Related
Qi Zhang1, Xin-Xing Wan2, Xi-Min Hu1
1Department of Anatomy and Neurobiology, School of Basic Medical Sciences, Central South University, Changsha, China.
Abstract:
Stem cell therapies have shown promising therapeutic effects in restoring damaged tissue and promoting functional repair in a wide range of human diseases. Generations of insulin-producing cells and pancreatic progenitors from stem cells are potential therapeutic methods for treating diabetes and diabetes-related diseases. However, accumulated evidence has demonstrated that multiple types of programmed cell death (PCD) existed in stem cells post-transplantation and compromise their therapeutic efficiency, including apoptosis, autophagy, necroptosis, pyroptosis, and ferroptosis. Understanding the molecular mechanisms in PCD during stem cell transplantation and targeting cell death signaling pathways are vital to successful stem cell therapies. In this review, we highlight the research advances in PCD mechanisms that guide the development of multiple strategies to prevent the loss of stem cells and discuss promising implications for improving stem cell therapy in diabetes and diabetes-related diseases.
Insights
Stem cell therapies for diabetes face challenges from programmed cell death (PCD) in transplanted cells. Targeting these cell death pathways is crucial for enhancing stem cell therapy effectiveness.
Area of Science:
- Regenerative Medicine
- Cell Biology
- Endocrinology
Background:
- Stem cell therapies offer potential for tissue repair in various diseases.
- Generating insulin-producing cells from stem cells is a promising approach for diabetes treatment.
- Programmed cell death (PCD) pathways, including apoptosis, autophagy, necroptosis, pyroptosis, and ferroptosis, limit stem cell efficacy post-transplantation.
Purpose of the Study:
- To review the mechanisms of programmed cell death in transplanted stem cells.
- To highlight strategies for preventing stem cell loss via PCD.
- To discuss implications for improving stem cell therapy in diabetes.
Main Methods:
- Literature review of programmed cell death mechanisms in stem cells.
- Analysis of research on targeting cell death pathways.
- Synthesis of findings related to stem cell therapy for diabetes.
Main Results:
- Multiple PCD pathways contribute to stem cell loss after transplantation.
- Understanding these PCD mechanisms is key to improving therapeutic outcomes.
- Strategies to inhibit PCD can enhance stem cell survival and function.
Conclusions:
- Preventing programmed cell death is essential for successful stem cell transplantation.
- Targeting PCD pathways holds significant promise for advancing diabetes treatment with stem cells.
- Further research into PCD mechanisms will optimize stem cell-based regenerative therapies.
Related Concept Videos
iPS Cell Differentiation
Stem Cell Culture
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Tissue Renewal without Stem Cells
However, failure of such a system...
Induced Pluripotent Stem Cells
Somatic...
Targeted Cancer Therapies
There are several types of targeted therapies against...

